Hims & Hers Health EBITDA Margin 2020-2025 | HIMS
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Hims & Hers Health (HIMS) over the last 10 years. The current EBITDA margin for Hims & Hers Health as of September 30, 2025 is .
| Hims & Hers Health EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-09-30 | $2.21B | $0.16B | 7.15% |
| 2025-06-30 | $2.01B | $0.15B | 7.60% |
| 2025-03-31 | $1.79B | $0.13B | 7.17% |
| 2024-12-31 | $1.48B | $0.08B | 5.08% |
| 2024-09-30 | $1.24B | $0.05B | 4.18% |
| 2024-06-30 | $1.07B | $0.02B | 1.69% |
| 2024-03-31 | $0.96B | $0.00B | -0.31% |
| 2023-12-31 | $0.87B | $-0.03B | -2.86% |
| 2023-09-30 | $0.79B | $-0.04B | -4.54% |
| 2023-06-30 | $0.71B | $-0.05B | -6.47% |
| 2023-03-31 | $0.62B | $-0.06B | -9.08% |
| 2022-12-31 | $0.53B | $-0.06B | -11.39% |
| 2022-09-30 | $0.45B | $-0.07B | -15.73% |
| 2022-06-30 | $0.37B | $-0.08B | -20.59% |
| 2022-03-31 | $0.32B | $-0.08B | -23.68% |
| 2021-12-31 | $0.27B | $-0.11B | -40.44% |
| 2021-09-30 | $0.23B | $-0.09B | -41.23% |
| 2021-06-30 | $0.20B | $-0.07B | -36.92% |
| 2021-03-31 | $0.17B | $-0.06B | -32.94% |
| 2020-12-31 | $0.15B | $-0.01B | -9.46% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $6.577B | $1.477B |
| Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $36.120B | 41.77 |
| Tempus AI (TEM) | United States | $11.621B | 0.00 |
| Doximity (DOCS) | United States | $7.503B | 30.89 |
| IRhythm Holdings (IRTC) | United States | $5.273B | 0.00 |
| Hinge Health (HNGE) | United States | $3.268B | 0.00 |
| Privia Health (PRVA) | United States | $2.903B | 181.54 |
| 10x Genomics (TXG) | United States | $2.870B | 0.00 |
| Heartflow (HTFL) | United States | $2.857B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.795B | 46.25 |
| Omnicell (OMCL) | United States | $2.265B | 46.31 |
| Azenta (AZTA) | United States | $1.857B | 76.17 |
| Enovis (ENOV) | United States | $1.354B | 7.11 |
| Clover Health Investments (CLOV) | United States | $1.354B | 0.00 |
| Schrodinger (SDGR) | United States | $1.210B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.117B | 0.00 |
| Phreesia (PHR) | United States | $0.942B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.861B | 0.00 |
| Talkspace (TALK) | United States | $0.633B | 127.33 |
| Standard BioTools (LAB) | United States | $0.631B | 0.00 |
| Claritev (CTEV) | United States | $0.477B | 0.00 |
| Evolent Health (EVH) | United States | $0.424B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.366B | 0.00 |
| Carlsmed (CARL) | United States | $0.352B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.331B | 0.00 |
| TruBridge (TBRG) | United States | $0.303B | 13.90 |
| Senseonics Holdings (SENS) | United States | $0.295B | 0.00 |
| CapsoVision (CV) | United States | $0.289B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.264B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.187B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.183B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.163B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.162B | 0.00 |
| CareCloud (CCLD) | United States | $0.124B | 6.81 |
| Outset Medical (OM) | United States | $0.094B | 0.00 |
| Pulmonx (LUNG) | United States | $0.077B | 0.00 |
| American Well (AMWL) | United States | $0.074B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.073B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.067B | 0.00 |
| HeartBeam (BEAT) | United States | $0.064B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.062B | 0.00 |
| 111 (YI) | China | $0.046B | 0.00 |
| Precipio (PRPO) | United States | $0.043B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.035B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.019B | 0.00 |
| Zhongchao (ZCMD) | China | $0.012B | 0.00 |
| HeartSciences (HSCS) | United States | $0.012B | 0.00 |
| PROFUSA (PFSA) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |